Physician profile
Mark J Albritton
NPI 1437144193
$19,519.80
in general payments reported to CMS, 2019-2025
7 companies · $365 in 2025
The $365 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $359 · 2021: $1,010 · 2022: $61.65 · 2023: $149 · 2024: $682 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $8,896.56 | 2019 | |
| Lima USA, INC. | $7,917.23 | 2019-2021 | |
| Depuy Synthes Sales INC. | $1,502.21 | 2019-2025 | N/A, Fms, Dynacord |
| Zimmer Biomet Holdings, INC. | $637.40 | 2020-2024 | Mymobility Platform |
| Depuy Synthes Products, INC. | $520.00 | 2021 | |
| Osprey Medical INC | $26.23 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $20.17 | 2024 | Onivyde |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Albritton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.